Trial Profile
Relationship between blood concentration and clinical outcomes of Everolimus in Patients With Advanced Renal Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacokinetics
- 11 Dec 2017 New trial record